Bonnie shares her story of being diagnosed with Alpha-1 Antitrypsin Deficiency and learning to manage the rare disease.

Shell is expected to report a 21% YoY top line contraction in Q2 2023 due to global economic weakness, despite ongoing inflationary pressures. Despite low expectations, Shell stock is considered ...

Shell plc is a textbook Hold: fair valuation, solid buybacks, and a decent dividend, but no major upside or hidden value from BP p.l.c. merger rumors. Both Shell and BP are prioritizing cash flow, ...